Search This Blog

Wednesday, May 8, 2024

Editas Medicine down 9% following rough Q1 results

 Editas Medicine (EDIT) reports disappointing Q1 results with a wider net loss, significant decline in revenue, and higher operating expenses

https://seekingalpha.com/news/4102550-editas-medicine-down-9-following-rough-q1-results

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.